drugset / Trial / NCT07265921
A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors
Phase 1
Recruiting
232 enrolled
Jiangsu Simcere Pharmaceutical Co., Ltd.
Shanghai Xianwei Medical Technology Co., Ltd. · collab
RandomizedSequentialOpen-labelTreatment
Summary
This is an open-label,multicenter phase I study to evaluate the safety,Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0609 in Adult Participants with Locally Advanced/Metastatic Solid Tumors
Timeline
- Start
- 2025-11-07
- Primary completion
- 2028-12
- Completion
- 2029-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SIM0609 | Unknown | — | — |